Combining forces: Synergy of erlotinib and crizotinib in a wild-type squamous non-small cell lung cancer cell line

被引：0
|
作者：
Van der Steen, Nele
Rolfo, Christian
Pauwels, Patrick
Peters, Godefridus J.
Giovannetti, Elisa
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1074
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line
    Van der Steen, Nele
    Leonetti, Alessandro
    Keller, Kaylee
    Dekker, Henk
    Funel, Niccola
    Lardon, Filip
    Ruijtenbeek, Rob
    Tiseo, Marcello
    Rolfo, Christian
    Pauwels, Patrick
    Peters, Godefridus J.
    Giovannetti, Elisa
    [J]. BIOCHEMICAL PHARMACOLOGY, 2019, 166 : 128 - 138
  • [2] Combining Erlotinib and Cetuximab Is Associated with Activity in Patients with Non-Small Cell Lung Cancer (Including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutations
    Wheler, Jennifer J.
    Tsimberidou, Apostolia M.
    Falchook, Gerald S.
    Zinner, Ralph G.
    Hong, David S.
    Fok, Jansina Y.
    Fu, Siqing
    Piha-Paul, Sarina A.
    Naing, Aung
    Kurzrock, Razelle
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) : 2167 - 2175
  • [3] ERLOTINIB IN METASTATIC, EGFR WILD-TYPE, NON-SMALL CELL LUNG CANCER (NSCLC) AS SECOND OR FURTHER LINE OF THERAPY
    Hernandez, Alba
    Calera, Lourdes
    Alvarez, Maria
    Hernando, Jorge
    Torres, Irene
    Pajares, Isabel
    Madani, Julia
    Cebollero, Ana
    Anton-Torres, Antonio
    Artal, Angel
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1017 - S1017
  • [4] A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer
    Wang, Duo
    Zhou, Jun
    Fang, Weimin
    Huang, Cuiqing
    Chen, Zerong
    Fan, Meng
    Zhang, Ming-Rong
    Xiao, Zeyu
    Hu, Kuan
    Luo, Liangping
    [J]. BIOACTIVE MATERIALS, 2022, 13 : 312 - 323
  • [5] Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case Report
    Polychronidou, Genovefa
    Papakotoulas, Pavlos
    [J]. CASE REPORTS IN ONCOLOGY, 2013, 6 (01): : 189 - 196
  • [6] Clinical and biological significance of erlotinib therapy after pemetrexed in non-small cell lung cancer with wild-type EGFR
    Koyama, N.
    Suzuki, M.
    [J]. NEOPLASMA, 2015, 62 (06) : 996 - 1004
  • [7] The efficacy of erlotinib for patients with non-small cell lung cancer with wild type of EGFR mutations
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Tanabe, Tsuyoshi
    Tsushima, Kenji
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Kubo, Keishi
    Koyama, Shigeru
    Ooura, Nariaki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S690 - S690
  • [8] Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer
    Bahcall, Magda
    Awad, Mark M.
    Sholl, Lynette M.
    Wilson, Frederick H.
    Xu, Man
    Wang, Stephen
    Palakurthi, Sangeetha
    Choi, Jihyun
    Ivanova, Elena V.
    Leonardi, Giulia C.
    Ulrich, Bryan C.
    Paweletz, Cloud P.
    Kirschmeier, Paul T.
    Watanabe, Masayuki
    Baba, Hideo
    Nishino, Mizuki
    Nagy, Rebecca J.
    Lanman, Richard B.
    Capelletti, Marzia
    Chambers, Emily S.
    Redig, Amanda J.
    VanderLaan, Paul A.
    Costa, Daniel B.
    Imamura, Yu
    Janne, Pasi A.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5963 - 5976
  • [9] Could erlotinib be used in EGF receptor wild-type non-small-cell lung cancer?
    Cheng, Haiying
    Piperdi, Bilal
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (05) : 333 - 336
  • [10] Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, L.
    Gray, J.
    Harb, W.
    Doebele, R.
    Modiano, M.
    Jackman, D.
    Baggstrom, M.
    Atmaca, A.
    Felip, E.
    Provencio, M.
    Cobo Dols, M.
    Adiwijaya, B.
    Kuesters, G.
    Kamoun, W.
    Andreas, K.
    Pipas, J.
    Santillana, S.
    Cho, B. C.
    Park, K.
    Shepherd, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S596 - S596
12345